Fujitsu and A*STAR Announces Joint R+D Partnership

Fujitsu and the Agency for Science Technology and Research (A*STAR)'s Institute of High Performance Computing (IHPC) announced today an R+D partnership to jointly develop advanced applications technologies for the next generation of scientific computing known as petascale computing.

Petascale computing, using sophisticated supercomputers able to undertake a quadrillion (1015) calculations per second, will provide unprecedented computing capability to solve highly complex and challenging scientific and engineering problems. To enable the effective use of the immense compute power of petascale supercomputers, a new set of compatible software applications will need to be built.

A joint team of 20 IHPC and Fujitsu researchers will develop scalable algorithms for petascale computing in the areas of computational fluid dynamics and materials science. To do so, the team will harness the compute power of Fujitsu supercomputer system comprising a cluster of Fujitsu PRIMERGY BX900 blade servers with a peak performance of over 35 teraflops(1) (TFlops) and 91.8% efficiency(2) with LINPACK(3) program . This is the first installation of a Fujitsu PRIMERGY BX900-based supercomputer outside of Japan. This system, housed at A*STAR's Computational Resource Centre (A*CRC) at Fusionopolis, will be amongst the top tier of supercomputer sites in the world and the most powerful in Southeast Asia.

The R&D in petascale computing applications will enable a very high degree of fidelity and accuracy, in the study of highly complex real and engineering systems. This know-how will lead to innovative and cutting-edge solutions for advanced applications in diverse areas such as chemicals to infocommunications and electronics. It can also address a wider range of large-scale scenarios from weather modeling to studies on infectious diseases.

Said Mr. Lim Chuan Poh, Chairman, A*STAR: "I am delighted to welcome Fujitsu into the research community at Fusionopolis and to A*STAR. This partnership will enable both parties to develop further capabilities to drive advances in high-performance computing. Over the years, A*STAR and Fujitsu have enjoyed close collaborations on R&D in the physical sciences, and I look forward to working with Fujitsu to expand these to also include the biomedical sciences. I am confident that such strategic partnerships will push the frontiers of research, enhance Fujitsu's ability to stay relevant and competitive, and also enable Singapore to harness innovation for the benefit of key industry sectors."

Said Dr. Raj Thampuran, Executive Director, IHPC: "Petascale computing is the new frontier in high-performance computing and will open avenues to solve complex problems in the physical and life sciences, as well as engineering. IHPC's expertise in computational science and engineering complements Fujitsu's skills in developing new architectures. We are privileged to partner with Fujitsu in this exciting endeavour."

Mr. Koichi Hironishi, Corporate Senior Executive Vice President, Fujitsu Limited, added: "Fujitsu is honored to collaborate with A*STAR and to contribute to the development of Singapore as the R&D hub of the region. We look forward to building a long-term collaboration to realize the potential of petascale computing and beyond in Singapore. The deployment of this supercomputer is an important first step."

"Since we started operations in Singapore, we have positioned the country as the showcase for the rest of Asia by introducing the best IT solutions and practices from our global experience to local customers and industry partners. This collaboration is the latest milestone in a series of contributions towards Singapore's continued economic success, and demonstrates our ability to value-add to the nation through strategic partnerships with industry prime movers such as A*STAR," added Mr. Masaki Kajiyama, President of Singapore operations at Fujitsu Asia.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.